{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:30:16Z","timestamp":1786980616126,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS122419"],"award-info":[{"award-number":["U01NS122419"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin. Auton. Res."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10286-026-01192-6","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:09:43Z","timestamp":1772269783000},"page":"233-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiple System Atrophy Combined Outcome Assessment (MuSyCA): process, format, and validation plan"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1851-9981","authenticated-orcid":false,"given":"Horacio","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1345-6774","authenticated-orcid":false,"given":"Jose-Alberto","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-3321","authenticated-orcid":false,"given":"Patricio","family":"Millar Vernetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechteld","family":"Kuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Nkrumah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Un Jung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Betensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel O.","family":"Claassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthi","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Siderowf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Feigin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn T.","family":"Stebbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Karin","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Husnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Fanciulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Poewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krismer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Biaggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the MuSyCA Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"1192_CR1","unstructured":"Food and Drug Administration (2024) Guidance Document: Early Alzheimer\u2019s Disease: Developing Drugs for Treatment. In: https:\/\/www.fda.gov\/media\/110903\/download"},{"key":"1192_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s00415-018-9121-3","volume":"266","author":"V Chelban","year":"2019","unstructured":"Chelban V, Bocchetta M, Hassanein S, Haridy NA, Houlden H, Rohrer JD (2019) An update on advances in magnetic resonance imaging of multiple system atrophy. J Neurol 266:1036\u20131045","journal-title":"J Neurol"},{"key":"1192_CR3","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1093\/brain\/awac253","volume":"145","author":"V Chelban","year":"2022","unstructured":"Chelban V, Nikram E, Perez-Soriano A, Wilke C, Foubert-Samier A, Vijiaratnam N, Guo T, Jabbari E, Olufodun S, Gonzalez M, Senkevich K, Laurens B, Peran P, Rascol O, Le Traon AP, Todd EG, Costantini AA, Alikhwan S, Tariq A, Ng BL, Munoz E, Painous C, Compta Y, Junque C, Segura B, Zhelcheska K, Wellington H, Schols L, Jaunmuktane Z, Kobylecki C, Church A, Hu MTM, Rowe JB, Leigh PN, Massey L, Burn DJ, Pavese N, Foltynie T, Pchelina S, Wood N, Heslegrave AJ, Zetterberg H, Bocchetta M, Rohrer JD, Marti MJ, Synofzik M, Morris HR, Meissner WG, Houlden H (2022) Neurofilament light levels predict clinical progression and death in multiple system atrophy. Brain 145:4398\u20134408","journal-title":"Brain"},{"key":"1192_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.trci.2016.12.004","volume":"3","author":"SD Edland","year":"2017","unstructured":"Edland SD, Ard MC, Li W, Jiang L (2017) Design of pilot studies to inform the construction of composite outcome measures. Alzheimers Dement (NY) 3:213\u2013218","journal-title":"Alzheimers Dement (NY)"},{"key":"1192_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10122459","author":"M Etoom","year":"2022","unstructured":"Etoom M, Jahan AM, Alghwiri A, Lena F, Modugno N (2022) Ataxia rating scales: content analysis by linking to the international classification of functioning, disability and health. Healthcare (Basel). https:\/\/doi.org\/10.3390\/healthcare10122459","journal-title":"Healthcare (Basel)"},{"key":"1192_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1177\/1352458517690824","volume":"23","author":"P Feys","year":"2017","unstructured":"Feys P, Lamers I, Francis G, Benedict R, Phillips G, LaRocca N, Hudson LD, Rudick R, Multiple Sclerosis Outcome Assessments C (2017) The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis. Mult Scler 23:711\u2013720","journal-title":"Mult Scler"},{"key":"1192_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2021.11.024","volume":"94","author":"A Foubert-Samier","year":"2022","unstructured":"Foubert-Samier A, Pavy-Le Traon A, Saulnier T, Le-Goff M, Fabbri M, Helmer C, Rascol O, Proust-Lima C, Meissner WG (2022) An item response theory analysis of the Unified Multiple System Atrophy Rating Scale. Parkinsonism Relat Disord 94:40\u201344","journal-title":"Parkinsonism Relat Disord"},{"key":"1192_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10286-022-00898-7","volume":"32","author":"EP Golden","year":"2022","unstructured":"Golden EP, McCreary M, Vernino S (2022) Responsiveness of UMSARS and other clinical measures in a longitudinal structured care clinic for multiple system atrophy. Clin Auton Res 32:477\u2013484","journal-title":"Clin Auton Res"},{"key":"1192_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/mds.20815","volume":"21","author":"T Ito","year":"2006","unstructured":"Ito T, Sakakibara R, Yasuda K, Yamamoto T, Uchiyama T, Liu Z, Yamanishi T, Awa Y, Yamamoto K, Hattori T (2006) Incomplete emptying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it? Mov Disord 21:816\u2013823","journal-title":"Mov Disord"},{"key":"1192_CR10","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1002\/mds.29215","volume":"37","author":"F Krismer","year":"2022","unstructured":"Krismer F, Palma JA, Calandra-Buonaura G, Stankovic I, Vignatelli L, Berger AK, Falup-Pecurariu C, Foubert-Samier A, Hoglinger G, Kaufmann H, Kellerman L, Kim HJ, Klockgether T, Levin J, Martinez-Martin P, Mestre TA, Pellecchia MT, Perlman S, Qureshi I, Rascol O, Schrag A, Seppi K, Shang H, Stebbins GT, Wenning GK, Singer W, Meissner WG (2022) The Unified Multiple System Atrophy Rating Scale: status, critique, and recommendations. Mov Disord 37:2336\u20132341","journal-title":"Mov Disord"},{"key":"1192_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/mds.29633","volume":"39","author":"F Krismer","year":"2024","unstructured":"Krismer F, Peran P, Beliveau V, Seppi K, Arribarat G, Pavy-Le Traon A, Meissner WG, Foubert-Samier A, Fabbri M, Schocke MM, Gordon MF, Wenning GK, Poewe W, Rascol O, Scherfler C (2024) Progressive brain atrophy in multiple system atrophy: a longitudinal, multicenter, magnetic resonance imaging study. Mov Disord 39:119\u2013129","journal-title":"Mov Disord"},{"key":"1192_CR12","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/mds.28993","volume":"37","author":"F Krismer","year":"2022","unstructured":"Krismer F, Seppi K, Jonsson L, Astrom DO, Berger AK, Simonsen J, Gordon MF, Wenning GK, Poewe W, European Multiple System Atrophy Study Group Natural History Study I, Rasagiline-for-Multiple System Atrophy I (2022) Sensitivity to change and patient-centricity of the Unified Multiple System Atrophy Rating Scale items: a data-driven analysis. Mov Disord 37:1425\u20131431","journal-title":"Mov Disord"},{"key":"1192_CR13","doi-asserted-by":"publisher","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","volume":"92","author":"J Kuhle","year":"2019","unstructured":"Kuhle J, Kropshofer H, Haering DA, Kundu U, Meinert R, Barro C, Dahlke F, Tomic D, Leppert D, Kappos L (2019) Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology 92:e1007\u2013e1015","journal-title":"Neurology"},{"key":"1192_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.102989","volume":"34","author":"M Lancione","year":"2022","unstructured":"Lancione M, Cencini M, Costagli M, Donatelli G, Tosetti M, Giannini G, Zangaglia R, Calandra-Buonaura G, Pacchetti C, Cortelli P, Cosottini M (2022) Diagnostic accuracy of quantitative susceptibility mapping in multiple system atrophy: the impact of echo time and the potential of histogram analysis. Neuroimage Clin 34:102989","journal-title":"Neuroimage Clin"},{"key":"1192_CR15","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1474-4422(24)00395-8","volume":"23","author":"Y Ma","year":"2024","unstructured":"Ma Y, Farris CM, Weber S, Schade S, Nguyen H, Perez-Soriano A, Giraldo DM, Fernandez M, Soto M, Camara A, Painous C, Munoz E, Valldeoriola F, Marti MJ, Clarimon J, Kallunki P, Ma TC, Alcalay RN, Gomes BF, Blennow K, Zetterberg H, Constantinescu J, Mengel D, Kadam V, Parchi P, Brockmann K, Tropea TF, Siderowf A, Synofzik M, Kang UJ, Compta Y, Svenningsson P, Mollenhauer B, Concha-Marambio L (2024) Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study. Lancet Neurol 23:1225\u20131237","journal-title":"Lancet Neurol"},{"key":"1192_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12311-015-0686-4","volume":"15","author":"M Matsushima","year":"2016","unstructured":"Matsushima M, Yabe I, Oba K, Sakushima K, Mito Y, Takei A, Houzen H, Tsuzaka K, Yoshida K, Maruo Y, Sasaki H (2016) Comparison of different symptom assessment scales for multiple system atrophy. Cerebellum 15:190\u2013200","journal-title":"Cerebellum"},{"key":"1192_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","volume":"387","author":"TM Miller","year":"2022","unstructured":"Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chio A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S, Valor, Group OLEW (2022) Trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med 387:1099\u20131110","journal-title":"N Engl J Med"},{"key":"1192_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrurol.2016.254","volume":"14","author":"T Ogawa","year":"2017","unstructured":"Ogawa T, Sakakibara R, Kuno S, Ishizuka O, Kitta T, Yoshimura N (2017) Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy. Nat Rev Urol 14:79\u201389","journal-title":"Nat Rev Urol"},{"key":"1192_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/mds.27344","volume":"33","author":"JA Palma","year":"2018","unstructured":"Palma JA, Kaufmann H (2018) Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord 33:372\u2013390","journal-title":"Mov Disord"},{"key":"1192_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/mds.28923","volume":"37","author":"JA Palma","year":"2022","unstructured":"Palma JA, Martinez J, Millar Vernetti P, Ma T, Perez MA, Zhong J, Qian Y, Dutta S, Maina KN, Siddique I, Bitan G, Ades-Aron B, Shepherd TM, Kang UJ, Kaufmann H (2022) mTOR inhibition with sirolimus in multiple system atrophy: a randomized, double-blind, placebo-controlled futility trial and 1-year biomarker longitudinal analysis. Mov Disord 37:778\u2013789","journal-title":"Mov Disord"},{"key":"1192_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10286-021-00782-w","volume":"31","author":"JA Palma","year":"2021","unstructured":"Palma JA, Vernetti PM, Perez MA, Krismer F, Seppi K, Fanciulli A, Singer W, Low P, Biaggioni I, Norcliffe-Kaufmann L, Pellecchia MT, Marti MJ, Kim HJ, Merello M, Stankovic I, Poewe W, Betensky R, Wenning G, Kaufmann H (2021) Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement. Clin Auton Res 31:157\u2013164","journal-title":"Clin Auton Res"},{"key":"1192_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00415-019-09597-2","volume":"267","author":"JN Panicker","year":"2020","unstructured":"Panicker JN, Simeoni S, Miki Y, Batla A, Iodice V, Holton JL, Sakakibara R, Warner TT (2020) Early presentation of urinary retention in multiple system atrophy: can the disease begin in the sacral spinal cord? J Neurol 267:659\u2013664","journal-title":"J Neurol"},{"key":"1192_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000511910","volume":"67","author":"T Paz","year":"2021","unstructured":"Paz T, de Britto VLS, Yamaguchi B, Israel VL, Swarowsky A, Lourenco Correa C (2021) Hand function as predictor of motor symptom severity in individuals with Parkinson\u2019s disease. Gerontology 67:160\u2013167","journal-title":"Gerontology"},{"key":"1192_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mds.28313","volume":"36","author":"S Perez-Lloret","year":"2021","unstructured":"Perez-Lloret S, van de Warrenburg B, Rossi M, Rodriguez-Blazquez C, Zesiewicz T, Saute JAM, Durr A, Nishizawa M, Martinez-Martin P, Stebbins GT, Schrag A, Skorvanek M, members of the MDSRSRC (2021) Assessment of ataxia rating scales and cerebellar functional tests: critique and recommendations. Mov Disord 36:283\u2013297","journal-title":"Mov Disord"},{"key":"1192_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3233\/JPD-202332","volume":"11","author":"A Perez-Soriano","year":"2021","unstructured":"Perez-Soriano A, Giraldo DM, Rios J, Munoz E, Compta Y, Marti MJ, Catalan MSAR (2021) Progression of motor and non-motor symptoms in multiple system atrophy: a prospective study from the Catalan-MSA registry. J Parkinsons Dis 11:685\u2013694","journal-title":"J Parkinsons Dis"},{"key":"1192_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00382-6","volume":"8","author":"W Poewe","year":"2022","unstructured":"Poewe W, Stankovic I, Halliday G, Meissner WG, Wenning GK, Pellecchia MT, Seppi K, Palma JA, Kaufmann H (2022) Multiple system atrophy. Nat Rev Dis Primers 8:56","journal-title":"Nat Rev Dis Primers"},{"key":"1192_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mds.29661","volume":"39","author":"A Rau","year":"2024","unstructured":"Rau A, Hosp JA, Rijntjes M, Weiller C, Kellner E, Berberovic E, Oikonomou P, Jost WH, Reisert M, Urbach H, Schroter N (2024) Cerebellar, not nigrostriatal degeneration impairs dexterity in multiple system atrophy. Mov Disord 39:130\u2013140","journal-title":"Mov Disord"},{"key":"1192_CR28","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/jnnp.71.5.600","volume":"71","author":"R Sakakibara","year":"2001","unstructured":"Sakakibara R, Hattori T, Uchiyama T, Yamanishi T (2001) Videourodynamic and sphincter motor unit potential analyses in Parkinson\u2019s disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 71:600\u2013606","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1192_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.parkreldis.2020.06.004","volume":"76","author":"A Santaella","year":"2020","unstructured":"Santaella A, Kuiperij HB, van Rumund A, Esselink RAJ, Bloem BR, Verbeek MM (2020) Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy. Parkinsonism Relat Disord 76:80\u201384","journal-title":"Parkinsonism Relat Disord"},{"key":"1192_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10286-023-00974-6","volume":"33","author":"W Singer","year":"2023","unstructured":"Singer W, Schmeichel AM, Sletten DM, Gehrking TL, Gehrking JA, Trejo-Lopez J, Suarez MD, Anderson JK, Bass PH, Lesnick TG, Low PA (2023) Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study. Clin Auton Res 33:635\u2013645","journal-title":"Clin Auton Res"},{"key":"1192_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2022.07.007","volume":"102","author":"T Tokutake","year":"2022","unstructured":"Tokutake T, Kasuga K, Tsukie T, Ishiguro T, Shimohata T, Onodera O, Ikeuchi T (2022) Clinical correlations of cerebrospinal fluid biomarkers including neuron-glia 2 and neurofilament light chain in patients with multiple system atrophy. Parkinsonism Relat Disord 102:30\u201335","journal-title":"Parkinsonism Relat Disord"},{"key":"1192_CR32","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/acn3.70106","volume":"12","author":"P Trujillo","year":"2025","unstructured":"Trujillo P, Hett K, Cooper A, Brown AE, Iregui J, Donahue MJ, Landman ME, Biaggioni I, Bradbury M, Wong C, Stamler D, Claassen DO (2025) The MSA atrophy index (MSA-AI): an imaging marker for diagnosis and clinical progression in multiple system atrophy. Ann Clin Transl Neurol 12:1823\u20131833","journal-title":"Ann Clin Transl Neurol"},{"key":"1192_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.parkreldis.2022.08.028","volume":"103","author":"P Vemuri","year":"2022","unstructured":"Vemuri P, Castillo AM, Thostenson KB, Ward CP, Raghavan S, Reid RI, Lesnick TG, Reddy AL, Gehrking TL, Gehrking JA, Sletten DM, Jack CR Jr., Low PA, Singer W (2022) Imaging biomarkers for early multiple system atrophy. Parkinsonism Relat Disord 103:60\u201368","journal-title":"Parkinsonism Relat Disord"},{"key":"1192_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/mds.28847","volume":"37","author":"L Zhang","year":"2022","unstructured":"Zhang L, Cao B, Hou Y, Gu X, Wei Q, Ou R, Zhao B, Luo C, Shang H (2022) Neurofilament light chain predicts disease severity and progression in multiple system atrophy. Mov Disord 37:421\u2013426","journal-title":"Mov Disord"},{"key":"1192_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02645-1","volume":"20","author":"L Zhang","year":"2022","unstructured":"Zhang L, Hou Y, Cao B, Wei Q, Ou R, Liu K, Lin J, Yang T, Xiao Y, Chen Y, Song W, Zhao B, Shang H (2022) Longitudinal evolution of motor and non-motor symptoms in early-stage multiple system atrophy: a 2-year prospective cohort study. BMC Med 20:446","journal-title":"BMC Med"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-026-01192-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-026-01192-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-026-01192-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:00:09Z","timestamp":1775797209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-026-01192-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1192"],"URL":"https:\/\/doi.org\/10.1007\/s10286-026-01192-6","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HK: Editor-in-Chief of\n                      Clinical Autonomic Research\n                      , published by Springer Nature, and serves as PI of studies sponsored by Biogen Inc. (TRACK MSA, S19-01846) and Vaxxinity Inc. (UB-312, S22-01332). He has received consultant fees from Takeda Pharmaceutical Company Ltd, Ono Pharma UK Ltd, Theravance Biopharma US Inc., Sanofi, Lundbeck, AskBio,\u00a0and Parexel. He receives royalties from UpToDate. He receives research support from NIH-NINDS, the Food and Drug Administration, the Familial Dysautonomia Foundation, and the HSAN IV Foundation. JAP: Research support from NIH-NINDS. Royalties from UpToDate. Salary from Eli Lilly. PMV: has received research funding from Theravance Biopharma. Site PI of clinical trial funded by Theravance Biopharma. MK: Nothing to disclose. GN: Nothing to disclose. UJK: Research support from NIH-NINDS. TM: Nothing to disclose. RAB: Nothing to disclose. DC: Nothing to disclose PV: Nothing to disclose. PT: Nothing to disclose. AS: Consultancies for SPARC Therapeutics, Capsida Therapeutics and Parkinson Study Group; honoraria from Bial; grants from The Michael J. Fox Foundation (member of PPMI Steering Committee); and participation on board at Wave Life Sciences, Inhibikase, Prevail, Huntington Study Group and Massachusetts General Hospital CS: Founder, Chief Scientific Officer and Member of the Board of Directors of Amprion Inc. AF: chair of the Huntington Study Group from 2018 to 2022. He is on the data and safety monitoring board for Alzheimer's Disease Cooperative Study\/Alzheimer's Therapeutic Research Institute and chairs a data and safety monitoring board for PTC Therapeutics. He has received institutional grant support to New York University, as a co-principal investigator of the LEGATO-HD study. He has also received grants to his institution, New York University, from Prilenia Therapeutics and the Huntington Study Group, and consulting fees from AskBio and Annexon. GTS: Consultancy fees from Contera Pharma, Eli Lilly, Neurocrine Biosciences, Pfizer, Vima Therapeutics. JL: Nothing to disclose. IQ: Employee of Biohaven Pharmaceuticals. AKB: Employee of Lundbeck. MH: Employee of Teva. WP: Consultancy fees from Alterity, AbbVie, Affiris, AstraZeneca, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, Novartis, Orion Pharma, Roche, Takeda, Teva, UCB, and Zambon. Royalties from Thieme, Wiley Blackwell, Oxford University Press and Cambridge University Press and a research grant support from The Michael J. Fox Foundation and EU FP7 and Horizon 2020. AF: Nothing to disclose. FK: Nothing to disclose. IB: Consultant for Theravance Biopharma, Amneal Pharmaceuticals, Regeneron Pharmaceuticals, Takeda Pharmaceuticals, and Neurawell Therapeutics. He is also a patent holder for an automated abdominal binder for the treatment of orthostatic hypotension and has submitted a patent application for the use of guanfacine in autonomic syndromes. WS: Nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}